Background Pin1 has previously been described to regulate cells that participate in both innate and adaptive immunity. Thus far, however, no role for Pin1 has been described in modulating conventional dendritic cells, innate antigen presenting cells that potently activate na？ve T cells, thereby bridging innate and adaptive immune responses. Methodology/Principal Findings When challenged with LPS, Pin1-null mice failed to accumulate spleen conventional dendritic cells (cDC). Analysis of steady-state spleen DC populations revealed that Pin1-null mice had fewer CD8+ cDC. This defect was recapitulated by culturing Pin1-null bone marrow with the DC-instructive cytokine Flt3 Ligand. Additionally, injection of Flt3 Ligand for 9 days failed to induce robust expansion of CD8+ cDC in Pin1-null mice. Upon infection with Listeria monocytogenes, Pin1-null mice were defective in stimulating proliferation of adoptively transferred WT CD8+ T cells, suggesting that decreases in Pin1 null CD8+ cDC may affect T cell responses to infection in vivo. Finally, upon analyzing expression of proteins involved in DC development, elevated expression of PU.1 was detected in Pin1-null cells, which resulted from an increase in PU.1 protein half-life. Conclusions/Significance We have identified a novel role for Pin1 as a modulator of CD8+ cDC development. Consistent with reduced numbers of CD8+ cDC in Pin1-null mice, we find that the absence of Pin1 impairs CD8+ T cell proliferation in response to infection with Listeria monocytogenes. These data suggest that, via regulation of CD8+ cDC production, Pin1 may serve as an important modulator of adaptive immunity.
References
[1]
Yeh ES, Means AR (2007) PIN1, the cell cycle and cancer. Nature reviews Cancer 7: 381–388.
[2]
Lu KP, Finn G, Lee TH, Nicholson LK (2007) Prolyl cis-trans isomerization as a molecular timer. Nature chemical biology 3: 619–629.
[3]
Atchison FW, Capel B, Means AR (2003) Pin1 regulates the timing of mammalian primordial germ cell proliferation. Development 130: 3579–3586.
[4]
Fujimori F, Takahashi K, Uchida C, Uchida T (1999) Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochemical and biophysical research communications 265: 658–663.
[5]
Yeh ES, Lew BO, Means AR (2006) The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. The Journal of biological chemistry 281: 241–251.
[6]
You H, Zheng H, Murray SA, Yu Q, Uchida T, et al. (2002) IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. Journal of cellular biochemistry 84: 211–216.
[7]
Lu KP, Zhou XZ (2007) The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nature reviews Molecular cell biology 8: 904–916.
[8]
Phan RT, Saito M, Kitagawa Y, Means AR, Dalla-Favera R (2007) Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells. Nature immunology 8: 1132–1139.
[9]
Esnault S, Braun RK, Shen ZJ, Xiang Z, Heninger E, et al. (2007) Pin1 modulates the type 1 immune response. PLoS One 2: e226.
[10]
Liu W, Youn HD, Zhou XZ, Lu KP, Liu JO (2001) Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1. FEBS letters 496: 105–108.
[11]
Shen ZJ, Esnault S, Malter JS (2005) The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils. Nature immunology 6: 1280–1287.
[12]
Shen ZJ, Esnault S, Rosenthal LA, Szakaly RJ, Sorkness RL, et al. (2008) Pin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. The Journal of clinical investigation 118: 479–490.
[13]
Shen ZJ, Esnault S, Schinzel A, Borner C, Malter JS (2009) The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation. Nature immunology 10: 257–265.
[14]
Saitoh T, Tun-Kyi A, Ryo A, Yamamoto M, Finn G, et al. (2006) Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nature immunology 7: 598–605.
[15]
Akiyama H, Misawa T, Ono M, Uchida C, Uchida T (2011) Prolyl isomerase pin1 protects mice from endotoxin shock. PLoS One 6: e14656.
[16]
Tun-Kyi A, Finn G, Greenwood A, Nowak M, Lee TH, et al. (2011) Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nature immunology 12: 733–741.
[17]
Savina A, Amigorena S (2007) Phagocytosis and antigen presentation in dendritic cells. Immunological reviews 219: 143–156.
[18]
Liu K, Nussenzweig MC (2010) Origin and development of dendritic cells. Immunological reviews 234: 45–54.
[19]
Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, et al. (2008) Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322: 1097–1100.
Swiecki M, Colonna M (2010) Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunological reviews 234: 142–162.
McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, et al. (2000) Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95: 3489–3497.
[24]
Waskow C, Liu K, Darrasse-Jeze G, Guermonprez P, Ginhoux F, et al. (2008) The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nature immunology 9: 676–683.
[25]
Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, et al. (1996) Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. The Journal of experimental medicine 184: 1953–1962.
[26]
Laouar Y, Welte T, Fu XY, Flavell RA (2003) STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19: 903–912.
[27]
Rankin L, Belz GT (2011) Diverse roles of inhibitor of differentiation 2 in adaptive immunity. Clinical & developmental immunology 2011: 281569.
[28]
Kashiwada M, Pham NL, Pewe LL, Harty JT, Rothman PB (2011) NFIL3/E4BP4 is a key transcription factor for CD8{alpha}+ dendritic cell development. Blood 117: 6193–6197.
[29]
Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, et al. (1999) Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proceedings of the National Academy of Sciences of the United States of America 96: 1036–1041.
[30]
McAleer JP, Vella AT (2008) Understanding how lipopolysaccharide impacts CD4 T-cell immunity. Critical reviews in immunology 28: 281–299.
[31]
Zanoni I, Granucci F (2010) Differences in lipopolysaccharide-induced signaling between conventional dendritic cells and macrophages. Immunobiology 215: 709–712.
[32]
Mannel DN (2007) Advances in sepsis research derived from animal models. International journal of medical microbiology: IJMM 297: 393–400.
[33]
Rathinam C, Geffers R, Yucel R, Buer J, Welte K, et al. (2005) The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity 22: 717–728.
[34]
Suzuki S, Honma K, Matsuyama T, Suzuki K, Toriyama K, et al. (2004) Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development. Proceedings of the National Academy of Sciences of the United States of America 101: 8981–8986.
[35]
Brasel K, De Smedt T, Smith JL, Maliszewski CR (2000) Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96: 3029–3039.
[36]
Xu Y, Zhan Y, Lew AM, Naik SH, Kershaw MH (2007) Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. Journal of immunology 179: 7577–7584.
[37]
Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nature reviews Immunology 5: 953–964.
[38]
Jackson JT, Hu Y, Liu R, Masson F, D'Amico A, et al. (2011) Id2 expression delineates differential checkpoints in the genetic program of CD8alpha+ and CD103+ dendritic cell lineages. The EMBO journal 30: 2690–2704.
[39]
Naik SH, Sathe P, Park HY, Metcalf D, Proietto AI, et al. (2007) Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nature immunology 8: 1217–1226.
[40]
Belz GT, Shortman K, Bevan MJ, Heath WR (2005) CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. Journal of immunology 175: 196–200.
[41]
Busch DH, Pamer EG (1999) T lymphocyte dynamics during Listeria monocytogenes infection. Immunology letters 65: 93–98.
[42]
Kapadia DSA, Vanloubbeeck Y, Brockstedt D, Fong L (2011) Interplay between CD8α+ Dendritic Cells and Monocytes in Response to Listeria monocytogenes Infection Attenuates T Cell Responses. PLoS ONE 6(4): e19376.
[43]
Watowich SS, Liu YJ (2010) Mechanisms regulating dendritic cell specification and development. Immunological reviews 238: 76–92.
[44]
Carotta S, Wu L, Nutt SL (2010) Surprising new roles for PU.1 in the adaptive immune response. Immunological reviews 238: 63–75.
[45]
Gangenahalli GU, Gupta P, Saluja D, Verma YK, Kishore V, et al. (2005) Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis. Stem cells and development 14: 140–152.
[46]
Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by proteolysis. Trends in biochemical sciences 21: 267–271.
[47]
Srinivasan S, Leeman SE, Amar S (2010) Beneficial dysregulation of the time course of inflammatory mediators in lipopolysaccharide-induced tumor necrosis factor alpha factor-deficient mice. Clinical and vaccine immunology: CVI 17: 699–704.
[48]
Turnbull IR, McDunn JE, Takai T, Townsend RR, Cobb JP, et al. (2005) DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. The Journal of experimental medicine 202: 363–369.
[49]
Edelson BT, Kc W, Juang R, Kohyama M, Benoit LA, et al. (2010) Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. The Journal of experimental medicine 207: 823–836.
[50]
Kashiwada M, Pham NL, Pewe LL, Harty JT, Rothman PB (2011) NFIL3/E4BP4 is a key transcription factor for CD8alpha dendritic cell development. Blood 117: 6193–6197.
[51]
Zenke M, Hieronymus T (2006) Towards an understanding of the transcription factor network of dendritic cell development. Trends in immunology 27: 140–145.
[52]
Engel I, Murre C (2001) The function of E- and Id proteins in lymphocyte development. Nature reviews Immunology 1: 193–199.
[53]
Hankey PA (2009) Regulation of hematopoietic cell development and function by Stat3. Frontiers in bioscience: a journal and virtual library 14: 5273–5290.
[54]
Hock H, Orkin SH (2006) Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cells. Current opinion in hematology 13: 1–6.
[55]
Wang H, Morse HC 3rd (2009) IRF8 regulates myeloid and B lymphoid lineage diversification. Immunologic research 43: 109–117.
[56]
Kamath AT, Pooley J, O'Keeffe MA, Vremec D, Zhan Y, et al. (2000) The development, maturation, and turnover rate of mouse spleen dendritic cell populations. Journal of immunology 165: 6762–6770.
[57]
Saito Y, Iwamura H, Kaneko T, Ohnishi H, Murata Y, et al. (2010) Regulation by SIRPalpha of dendritic cell homeostasis in lymphoid tissues. Blood 116: 3517–3525.
[58]
O'Keeffe M, Hochrein H, Vremec D, Pooley J, Evans R, et al. (2002) Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99: 2122–2130.
[59]
Natoli G, Ghisletti S, Barozzi I (2011) The genomic landscapes of inflammation. Genes & development 25: 101–106.
[60]
Dahl R, Iyer SR, Owens KS, Cuylear DD, Simon MC (2007) The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction. The Journal of biological chemistry 282: 6473–6483.
[61]
Marecki S, Fenton MJ (2000) PU.1/Interferon Regulatory Factor interactions: mechanisms of transcriptional regulation. Cell biochemistry and biophysics 33: 127–148.
[62]
Nutt SL, Metcalf D, D'Amico A, Polli M, Wu L (2005) Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. The Journal of experimental medicine 201: 221–231.
[63]
DeKoter RP, Kamath MB, Houston IB (2007) Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models. Blood cells, molecules & diseases 39: 316–320.
[64]
Bakri Y, Sarrazin S, Mayer UP, Tillmanns S, Nerlov C, et al. (2005) Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood 105: 2707–2716.
[65]
Hamdorf M, Berger A, Schule S, Reinhardt J, Flory E (2010) PKCdelta-induced PU.1 Phosphorylation Promotes Hematopoietic Stem Cell Differentiation to Dendritic Cells. Stem cells.
[66]
Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, et al. (2003) Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Molecular cell 12: 1413–1426.
[67]
Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, et al. (2004) A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nature cell biology 6: 308–318.
[68]
Dougherty MK, Muller J, Ritt DA, Zhou M, Zhou XZ, et al. (2005) Regulation of Raf-1 by direct feedback phosphorylation. Molecular cell 17: 215–224.
[69]
Zhang N, Hopkins K, He YW (2008) The long isoform of cellular FLIP is essential for T lymphocyte proliferation through an NF-kappaB-independent pathway. Journal of immunology 180: 5506–5511.
[70]
Winkler KE, Swenson KI, Kornbluth S, Means AR (2000) Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 287: 1644–1647.
